-
NOV 01, 2022 | 7:00 AM
C.E. CREDITS
Date: November 01, 2022 Time: 7:00am (PDT), 10:00am (EDT), 3:00pm (CET) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data t...
OCT 26, 2022 | 11:00 AM
C.E. CREDITS
Date: October 26, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) To control and monitor the epidemiology and diffusion of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
OCT 26, 2022 | 10:00 AM
C.E. CREDITS
Date: October 26, 2022 Time: 10:00am (PDT), 1:00pm (EDT) In this webinar, Dr. Becky Winslow, infectious disease clinical scientist, details urinary tract infections’ inc...
OCT 26, 2022 | 6:00 AM
C.E. CREDITS
Date: October 26, 2022 Time: 6:00am (PDT), 9:00pm (EDT), 3:00pm (CEST) In the global fight toward Hepatitis C elimination, hear insights into how to build a cost-effective screening program...
OCT 20, 2022 | 11:00 AM
C.E. CREDITS
Date: October 20, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Bacterial and viral infections produce a wide range of similar signs and symptoms leading often to the inappropriate u...
OCT 20, 2022 | 9:00 AM
C.E. CREDITS
Date: October 13, 2022 Time: 11:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Single-cell atlases mapping immune cells provide hints on how immune cells mature, attenuate, and disseminate through...
OCT 20, 2022 | 8:00 AM
C.E. CREDITS
Date: October 20, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Over the past three decades, baculovirus expression vector system (BEVS) has become one of the most powerful and robus...
OCT 20, 2022 | 2:00 PM
C.E. CREDITS
Date: October 20, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CET) Many laboratories around the world have adopted expanded diagnostic testing capabilities to address the coronavirus pan...
OCT 19, 2022
 | 5:30 AM PDT
C.E. CREDITS
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 19, 2022 | 1:30 PM
C.E. CREDITS
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...